SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Trends > Phood

Phood

Phood

The space between pharmaceuticals and food is getting smaller...and bigger

Artificial Intelligence: BASF partner with Nuritas on 'next gen' functional peptides

Ingredients giant BASF will collaborate with Irish start-up Nuritas on the discovery and commercialisation of novel functional peptides using DNA analysis and artificial intelligence (AI).

FREE online event: 26 January, 9am Paris time

I-nutrition: This time it’s personal

Personalised nutrition is emerging fast – as technologies like gene mapping and smartphones offer the potential for people to optimise nutrition, live healthier lives and reduce the burden of chronic...

BioGaia’s probiotic products to be launched in Thailand

BioGaia has signed an exclusive agreement with Abbott to commercialize its probiotic products  in Thailand.

KitoZyme banking on novel prebiotic with new medical device platform

Belgian firm KitoZyme is planning a roll out of of medical device products that put restoring gut flora at centre stage, company told Nutraingredients after receiving two new certifications.

Wild banana ripe for greater functional food and nutraceutical examination: Review

Wild banana (M. acuminata), which has long been used in traditional medicine in South East Asia, is worthy of further investigation to assess its functional food and nutraceutical development on...

French group: Vitamin D-linked infant death not a supplement issue; Health Minister agrees

The French food supplements trade group Synadiet has clarified that the Uvestérol D vitamin D product linked to an infant death before Christmas was a prescription-only medicine and not available...

News in brief

Asian VC invests €33m in Indian botanicals specialist; acquisitions targeted

Indian-based but global-facing herbals player OmniActive Health Technologies has won a $35 million (€33m) investment from venture capitalist Everstone Group, as it pursues expansion and acquisition targets.

The nutra space: Eyes turn to 2017

Only the seemingly foolish would have predicted 2016 would see the UK vote to leave the EU and Donald Trump win the US presidential election. But in the post-truth era,...

DuPont gets Gates grant for protein drug production platform

DuPont has joined a Gates Foundation backed effort to develop low cost production methods for therapeutic proteins.

News in brief

Firms invest €1.25m in ‘next generation of probiotic products’ for pregnant women

Swedish biotek firm MetaboGen is developing probiotic products to tackle pregnancy itching with Swiss player Ferring.

LGC seals third deal in a month with BRC Global Standards acquisition

Private equity backed LGC has splashed the cash for the third time in a month to acquire BRC Global Standards.

Tomato extract shows blood thinning potential versus aspirin: Study

A proprietary tomato extract – backed in EU health claim law to benefit blood circulation – has been shown to thin blood in healthy people – but less severely than...

ASA U-turn: Omega Pharma ruling reversed after UK medicines agency input

The UK Advertising Standards Authority (ASA) has reversed its ruling against healthcare company Omega Pharma following previously omitted advice from the UK’s medicines regulator.

Personalised nutrition: Thoughts from industry leaders at HiE

Personalised nutrition continues to inch its way into the mainstream but is progress certain and what challenges remain? And what is biohacking?

HiE opens arms to European and global nutrition sector

UBM-owned Health ingredients Europe & Natural ingredients (HiE & Ni) kicks off in Frankfurt on November 29. We asked brand director Richard Joyce how the 3-day mega-show is shaping up.

News in brief

Indian carotenoid player enters Europe

Bangalore-based lutein and carotenoid specialist Katra Phyto has enlisted UK-based ingredient player and distributor Gee Lawson as its European partner.

News in brief

Nestlé lowers full-year sales outlook

Nestlé has lowered its full year outlook from 4.2% to 3.5% as it feels the effect of a deflationary market.

Trend tracker

Pharma vitamins are the next big thing: DSM

DSM’s president of nutrition and health says high-dose vitamin and mineral products marketed via pharma channels are growing rapidly.

Infant nutrient found to lower hospital infection rate: Study

A protein that forms a key component of infant nutrition may play a significant role in reducing hospital-acquired infections in neonatal intensive care, according to US researchers. 

Liver function probiotic addresses ‘unmet clinical need’

OMNi-BiOTiC HETOX, an eight-strain probiotic formulation from Institut Allergosan, is the first product to present a therapeutic alternative to organ transplants for sufferers of liver disease.

THMPD: Has it delivered?

There is a clear divide in the way the THMPD has been implemented across Europe, with the UK and Germany on one side; Italy, France and Belgium on the other.

News in brief

Nestlé Health Science founding chief retires after 40 years

Luis Cantarell, who headed up €500m+ food-pharma crossover research centre Nestlé Health Science when it launched in 2010, is retiring after 40 years at the Swiss food giant.

Beta-glucan & fibre: Golden oldies in 2016?

Simple, recognisable nutrients like beta-glucan and fibre should be on the menu when targeting a new wave of active and positive seniors, say experts.

Unhealthy obsession with total cholesterol reduction is thwarting CVD prevention

Strategies to tackle cardiovascular disease (CVD) need to move away from statins and cholesterol reduction and focus on reducing inflammation and increasing HDL cholesterol through dietary intervention, urges a leading...

EU rejects more than 90% of all health claims: Study

The EU has authorised only a small fraction of the health claims submitted to it, with a number of categories seeing no authorised claims at all, according to a new...